January 29, 2026 /

Webinar: Sarepta Therapeutics – Community Update on ELEVIDYS

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

On January 26, 2026, Sarepta Therapeutics joined PPMD for a breaking news community webinar to discuss the recently released three-year top line data for ELEVIDYS, Sarepta’s gene therapy for the treatment of Duchenne. The presentation included a review of the data, a timely discussion of what this means for the community and next steps, as well as a dedicated Q&A period.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo